Paul Clancy has been appointed executive vice president and chief financial officer, Biogen Idec. He reports to James C. Mullen, the company’s chief executive officer, and most recently served as senior vice president of finance, responsible for leading the treasury, tax, investor relations and business planning groups. “Paul brings more than 20 years of experience in financial management and strategic business planning,” Mr. Mullen said. “In his six years at Biogen ...